The Effects of Luo-Bu-Fu-Ke-Bi-RI Pill

NCT05846698 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 276

Last updated 2023-08-24

No results posted yet for this study

Summary

To investigate the effect of LBFKBRP on climacteric syndrome in women and explore its therapeutic mechanism.

Conditions

  • Climacteric Syndrome

Interventions

DRUG

Luo-Bu-Fu-Ke-Bi-RI Pill

10 pills twice daily

DRUG

tibolone

2.5 mg once daily

Sponsors & Collaborators

  • Guoqing Zhou

    lead OTHER

Eligibility

Min Age
41 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05846698 on ClinicalTrials.gov